{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:36:23Z","timestamp":1784752583468,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.molimm.2008.04.016","type":"journal-article","created":{"date-parts":[[2008,6,17]],"date-time":"2008-06-17T08:40:50Z","timestamp":1213692050000},"page":"3631-3638","source":"Crossref","is-referenced-by-count":27,"title":["KIR2DS5 is associated with leukemia free survival after HLA identical stem cell transplantation in chronic myeloid leukemia patients"],"prefix":"10.1016","volume":"45","author":[{"given":"Arnold","family":"van der Meer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaas P.M.","family":"Schaap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton V.M.B.","family":"Schattenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"van Cranenbroek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk J.","family":"Tijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2008.04.016_bib1","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1182\/blood-2003-11-3893","article-title":"Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors","volume":"103","author":"Bornhauser","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2008.04.016_bib2","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1084\/jem.20042158","article-title":"Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci","volume":"201","author":"Carrington","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2008.04.016_bib3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0198-8859(03)00042-9","article-title":"A Multi-Laboratory characterization of the KIR genotypes of 10th International Histocompatibility Workshop cell lines","volume":"64","author":"Cook","year":"2003","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.molimm.2008.04.016_bib4","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1182\/blood-2003-02-0438","article-title":"The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia","volume":"103","author":"Cook","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2008.04.016_bib5","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1182\/blood.V99.10.3661","article-title":"Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia","volume":"99","author":"Costello","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2008.04.016_bib6","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1182\/blood-2002-04-1197","article-title":"Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor","volume":"100","author":"Davies","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2008.04.016_bib7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1365-2141.1995.tb05150.x","article-title":"Expansion of CD8+CD57+ T cells after allogeneic BMT is related with a low incidence of relapse and with cytomegalovirus infection","volume":"90","author":"Dolstra","year":"1995","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molimm.2008.04.016_bib8","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1097\/01.TP.0000164500.16052.3C","article-title":"Reduced risk for molecular disease in patients with chronic myeloid leukemia after transplantation from a KIR-mismatched donor","volume":"79","author":"Elmaagacli","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.molimm.2008.04.016_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0198-8859(02)00373-7","article-title":"Relevance of KIR gene polymorphisms in bone marrow transplantation outcome","volume":"63","author":"Gagne","year":"2002","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.molimm.2008.04.016_bib10","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/blood-2003-01-0091","article-title":"Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors","volume":"102","author":"Giebel","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2008.04.016_bib11","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1084\/jem.20041214","article-title":"Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success","volume":"200","author":"Hiby","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2008.04.016_bib12","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.4049\/jimmunol.169.9.5118","article-title":"Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets","volume":"169","author":"Hsu","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.04.016_bib13","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1182\/blood-2004-12-4825","article-title":"Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes","volume":"105","author":"Hsu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2008.04.016_bib14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1600-065X.2006.00459.x","article-title":"KIR and disease: a model system or system of models?","volume":"214","author":"Khakoo","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molimm.2008.04.016_bib15","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1097670","article-title":"HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection","volume":"305","author":"Khakoo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.molimm.2008.04.016_bib16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4049\/jimmunol.172.1.644","article-title":"Determinants of antileukemia effects of allogeneic NK cells","volume":"172","author":"Leung","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.04.016_bib17","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.4049\/jimmunol.174.10.6540","article-title":"Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors","volume":"174","author":"Leung","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.04.016_bib18","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1182\/blood-2007-01-065383","article-title":"Missing KIR-ligands is associated with less relapse and increased graft versus host disease (GVHD) following unrelated donor allogeneic HCT","volume":"109","author":"Miller","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2008.04.016_bib19","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nri956","article-title":"Natural killer cells and dendritic cells: rendezvous in abused tissues","volume":"2","author":"Moretta","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2008.04.016_bib20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00262-004-0575-z","article-title":"Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals","volume":"54","author":"Naumova","year":"2005","journal-title":"Cancer Immunol. Immunother"},{"key":"10.1016\/j.molimm.2008.04.016_bib21","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.4049\/jimmunol.173.7.4273","article-title":"Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection\/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis","volume":"173","author":"Nelson","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.04.016_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.V94.1.333.413a31_333_339","article-title":"Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation","volume":"94","author":"Ruggeri","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2008.04.016_bib23","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.molimm.2008.04.016_bib24","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1046\/j.1365-2141.1997.d01-3499.x","article-title":"Outcome of transplantation for standard-risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimen","volume":"98","author":"Schaap","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molimm.2008.04.016_bib25","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1182\/blood.V75.6.1356.1356","article-title":"Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugation","volume":"75","author":"Schattenberg","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2008.04.016_bib26","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.molimm.2007.11.014","article-title":"Activating KIRs exert a crucial role on relapse and overall survival after HLA-identical sibling transplantation","volume":"45","author":"Schellekens","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2008.04.016_bib27","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1182\/blood-2005-02-0479","article-title":"The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target cell interaction","volume":"106","author":"Sconocchia","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2008.04.016_bib28","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.2337\/diabetes.52.10.2639","article-title":"KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects","volume":"52","author":"van der Slik","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.molimm.2008.04.016_bib29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1034\/j.1399-0039.2000.560510.x","article-title":"Discovery of two novel variants of KIR2DS5 reveals this gene to be a common component of human KIR \u2018B\u2019 haplotypes","volume":"56","author":"Vilches","year":"2000","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.molimm.2008.04.016_bib30","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20051884","article-title":"Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function","volume":"203","author":"Yawata","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2008.04.016_bib31","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0198-8859(98)00078-0","article-title":"Independent contributions of HLA epitopes and killer inhibitory receptor expression to the functional alloreactive specificity of natural killer cells","volume":"59","author":"Young","year":"1998","journal-title":"Hum. Immunol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589008001739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589008001739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T10:34:23Z","timestamp":1588761263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589008001739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":31,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0161589008001739"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2008.04.016","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}